当前位置: X-MOL 学术Allergy › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
SM17, a new IL‐17RB‐targeting antibody, ameliorates disease progression in a mouse model of atopic dermatitis
Allergy ( IF 12.4 ) Pub Date : 2024-04-09 , DOI: 10.1111/all.16120
Lik Hang Lam 1 , Weimin Li 1 , Wai Chung Wu 1 , Kai Cheung Chow 1 , Wai Yin Dennis Au 1 , Guolin Xu 2 , Ge Wang 2 , Xuchen Qian 2 , Ka Man Ng 3 , Shaik Abdullah Nawabjan 3 , Muthu Iswarya Gandhi Sethuraman 3 , Wai Yan Choi 3 , Billy Kwok Chong Chow 3 , Shui On Leung 1 , Chin Wai Hui 1
Affiliation  



中文翻译:

SM17 是一种新型 IL-17RB 靶向抗体,可改善特应性皮炎小鼠模型的疾病进展

更新日期:2024-04-09
down
wechat
bug